HealthQuill Research
The Japanese name of the book is an expression used to describe people whom society considers to be failures
Health Opinion Research

The Tomoe test: Self-taught schools need open skies, human touch, peers

A modern home can love a child deeply, but without open skies and rich human interaction, love alone is not enough. Homeschooling can.

Read More
AstraZeneca, Daiichi’s breast cancer drug trial results show improvement in progression-free survival
Health Research

Research reveals first child after age 30 increases breast cancer risk by over 40%

HQ Team August 18, 2025: Research finds that women who have their first child after age 30 face a 40% to 45% higher.

Read More
Seventeen types of cancer are common in US millennials and the incidence rate for some forms is two to three times higher in people born in 1990 than in 1995, a study reveals.
Drugs Pharma Research

Immunotherapy drug shows promising results against metastatic cancers

HQ Team August 16, 2025: Phase I clinical trial of the CD40 agonist antibody drug 2141-V11, developed by Rockefeller University’s Jeffrey V. Ravetch.

Read More
Semaglutide based weightloss drugs tied to increased suicide risk in a new study
Health Research

Researchers identify natural alternative to Ozempic: Promising weight loss option

HQ Team August 12, 2025: Researchers from Jiangnan University in China have discovered a potential natural alternative to Ozempic, a popular GLP-1 receptor.

Read More
Climate Research

Lightning kills 320 million trees annually, climate change will escalate toll further

HQ Team August 12, 2025: A study published in the journal Global Change Biology has revealed that lightning kills approximately 320 million trees.

Read More
Novartis AG, a global Switzerland-based pharmaceutical company, has agreed to pay Monte Rosa Therapeutics Inc., $150 million upfront to develop, manufacture and commercialise drug candidates, mainly in immunology.
Drugs Research

Novartis’s Ianalumab has positive Phase III results for Sjögren’s Syndrome

HQ Team August. 11, 2025: Novartis AG announced positive Phase III trial results for its experimental autoimmune drug, Ianalumab (VAY736), in treating Sjögren’s.

Read More
About 67 million people globally living with chronic fatigue syndrome have different genes compared to their healthy counterparts, initial findings from the world's largest research study on the illness reveal.
Health Pharma Research

UK researchers unravel 8 gene variants in chronic fatigue syndrome 

About 67 million people globally living with chronic fatigue syndrome have different genes compared to their healthy counterparts, initial findings from the world's.

Read More
A 15-minute fast walk helped reduce mortality by 20%, mostly in low-income Black individuals in the US, a study finds.
Health Medical Research

A 15-minute brisk walk may cut mortality rate by 20%: Vanderbilt

A 15-minute fast walk helped reduce mortality by 20%, mostly in low-income Black individuals in the US, a study finds.

Read More
The US Food and Drug Administration has approved Nuvation Bio Inc.’s medicine for adults who have a rare type of lung cancer caused by a specific genetic change.
Health Research

Physicians using AI viewed as less competent and trustworthy

HQ Team August 2, 2025: A new study conducted by Moritz Reis from the University of Wuerzburg in Germany and colleagues has shed.

Read More
Biogen Inc., a US biotechnology company, has got marketing authorisation from the European medicines regulator for its drug to treat neurodegenerative disease, amyotrophic lateral sclerosis.
Health Research

Not all low-grade prostate cancers are low risk: New study finds 30% risk

HQ Team August 2, 2025: A study published in JAMA Oncology is challenging the conventional belief that men diagnosed with Grade Group One.

Read More